UK pain management research in the Wall Street Journal

Peter Crooks' study on a potential new drug to treat chronic and acute pain was reported in the January 11, 2011 edition of the Wall Street Journal. According to the WSJ, Crooks and his team tested their opioid morphine analog, morphine-6-O-sulfate, on laboratory rats and found it was at least 10 times as potent as morphine depending on how it was administered. Opioids are the most common treatment for pain, but can have undesirable side effects, such as addiction. The UK morphine derivative showed fewer side effects in the study published in the European Journal of Pharmacology. Peter Crooks is internationally known for his research work in drug discovery, delivery, and development, and is the founder/cofounder of six drug discovery companies. Several drugs discovered in his laboratory are currently in various phases of clinical development.

Scroll down to the bottom of this page to view "Antinociceptive effects and toxicity of morphine-6-0-sulfate sodium salt in rat models of pain."